Initial strategies for integrating buprenorphine into HIV care settings in the United States.
about
The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban settingOptimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparitiesConsumer attitudes about opioid addiction treatment: a focus group study in New York City.Buprenorphine treatment in an urban community health center: what to expectImproved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatmentLinkage to care for HIV-infected heterosexual men in the United StatesImproving public health through access to and utilization of medication assisted treatmentProgress in HIV reduction and prevention among injection and noninjection drug users.Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems.Narrative review: buprenorphine for opioid-dependent patients in office practice.Latent tuberculosis infection: screening and treatment in an urban setting.Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care.
P2860
Q21559628-96AAB35C-0687-436C-AEE8-BF7C3DEEC19DQ26865313-179837B9-406A-491C-8610-C95463BFA67BQ33576957-405008E9-B856-429D-AA48-F9B048529267Q33735289-F5116AB5-BE19-4287-A8D5-F0B321C36115Q33977281-A6B4453A-4095-4E64-85BC-B3F24511CED1Q35019900-A18E8F49-720A-4B89-8785-8F824D72B3A7Q35534893-67156A77-6E4F-401C-BA62-94355F882182Q35816921-D1ABA820-61A8-4C96-AF62-E27D1B9BE2BFQ36431907-482A80AB-2690-4B75-B29D-77A3B86DF2E7Q36959052-B4EB476D-8278-4FD7-A237-4D795FF2AA33Q37193747-2DA8B1ED-AED3-4463-A1E7-BDA84692BD3DQ43218767-C5F284C7-0E22-478D-8867-DDD513F7B591Q51704142-416BD57A-C1EA-404F-ADC5-36037570926D
P2860
Initial strategies for integrating buprenorphine into HIV care settings in the United States.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Initial strategies for integra ...... settings in the United States.
@ast
Initial strategies for integra ...... settings in the United States.
@en
type
label
Initial strategies for integra ...... settings in the United States.
@ast
Initial strategies for integra ...... settings in the United States.
@en
prefLabel
Initial strategies for integra ...... settings in the United States.
@ast
Initial strategies for integra ...... settings in the United States.
@en
P2093
P356
P1476
Initial strategies for integra ...... settings in the United States.
@en
P2093
David Haltiwanger
Gregory M Lucas
Lois Eldred
Lynn E Sullivan
Robert D Bruce
Ruth Finkelstein
P304
P356
10.1086/508183
P407
P478
43 Suppl 4
P577
2006-12-01T00:00:00Z